Study to Compare the Safety and Efficacy of UB-851 and Eprex®
Clinical trial NCT02708914 · COMPLETED
Trial details
- NCT number
- NCT02708914
- Sponsor
- UBI Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2021-10-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.